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Abstract
In this report two cases of the coincidence of hyperimmunoglobulinemia D syndrome (HIDS) and pregnancy are described. HIDS 
is not associated with complications in pregnancy or disturbance in fetal outcome; the frequency of attacks diminishes during preg­
nancy; HIDS probably inherits via an autosomal recessive trait and is not transmitted to children of patients.
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1. Case Reports
Case 1
A 31-year-old woman of Dutch offspring, gravida 1 
para 0, presented to our department because of 
hyperemesis gravidarum at nearly 7 weeks’ gestation* 
Since her tenth year of age she was suffering from at­
tacks of high spiking fever with mild abdominal pain 
and arthritis, without any swelling of lymph nodes or 
skin manifestations; these episodes occurred five to eight 
times a year. Serum IgD was 257 U/ml (normal <100
U/ml) and a diagnosis of hyperimmunoglobulinemia D 
syndrome (HIDS) was made. There were no family 
members with HIDS. Besides a D & C for metrorrhagia, 
her gynaecologic history was unremarkable. She was ad­
mitted into the hospital for protracted nausea and 
vomiting without fever. There was ketonuria, but all 
other appropriate laboratory investigations, including 
TSH, fT4 and immunoglobulins, were normal. Treat­
ment was delivered by infusion of glucose solutions and 
guidance by a psychologist. The complaints resolved 
after 2 weeks and she was discharged. Because of recur­
rence of symptoms 1 week later, readmission was
m
necessary, this time requiring parenteral nutrition. After
* Corresponding author, Tel: +31 40 2399111; fax: +31 40 2397104.
discharge there was a normal obstetrical follow-up. At 
38 weeks membranes ruptured spontaneously. Labour 
was without complications and a healthy male infant
was bom weighing 3120 g, with good Apgar scores. The 
placenta was clinically and histologically normal. IgD in 
cord serum was 0.12 U/ml. Puerperium was un­
complicated. During pregnancy as well as the first 3 
months after delivery there were no attacks of fever.
Case 2
A woman of Dutch parentage had her first period of 
fever after vaccination against measles in her first year 
of life. After that, attacks of high fever sometimes with 
skin lesions, arthritis, abdominal pain, diarrhea and 
swelling of lymph nodes occurred every month. Tetanus 
vaccination provoked the same clinical picture. Her 
serum IgD was 4995 U/ml and the diagnosis of HIDS 
was delivered when she was 20 years old (patient #1 in 
a recent review) [1], Menstruation coincided with or was 
preceded by attacks [2]* Her family history for the 
disease was negative. Because of the good results in 
Familial Mediterranean Fever (FMF), colchicine thera­
py was started (0.5 mg twice daily) with disappointing 
results. During her first pregnancy at the age of 27, she 
had only two episodes of fever, both times in the second 
trimester, while her serum IgD was 1620 U/ml. A
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healthy boy was bom. No IgD was detectable in cord 
serum. Since then, she had monthly attacks again. In her 
second pregnancy 4 years later, there were only two 
minor febrile episodes. A healthy boy was bom again. 
After 5 days she was admitted with high fever, due to 
sepsis with iStreptococcus Hemolyticus Group A. At D &
C, endometritis was diagnosed and retained pieces of the 
placenta were removed. Treatment with antibiotics and 
artificial respiration was started with good result.
2. Discussion
Hyper-IgD Syndrome (HIDS) is a rare disorder, in 
some aspects resembling Familial Mediterranean Fever 
(FMF). The syndrome is characterized by recurrent 
episodes of fever, sometimes preceded by chills, and 
starting early in life [1]. Typically, these attacks occur 
every 4 -8  weeks and may last about 3 -7  days. Associ­
ated symptoms may be divergent: lymphadenopathy, 
mostly cervical, abdominal pain with vomiting and diar­
rhea, headache, splenomegaly, recurrent arthritis in 
large joints and typical skin lesions. Laboratory testing 
reveals an elevated immunoglobulin D (IgD) (>100  
U/ml) and in 80% a concomitant elevated IgA. The com­
bination of the typical clinical picture and the high 
serum IgD will lead to the diagnosis. Unfortunately thus
far no satisfactory treatment is available but apart from 
the recurrent attacks, prognosis appears to be good.
Until now HIDS has been described in 66 patients (33 
males; 33 females). So far the syndrome has never been 
described specifically in combination with pregnancy. 
Apart from the hyperemesis gravidarum in our first 
case, both patients had favourable pregnancies. In­
cluding our patients, at least five HIDS patients have 
been pregnant and delivered healthy children. These 
limited data may suggest that there is no vertical trans­
mission of the disease. The analysis of clinical data and 
IgD levels in families favor an autosomal recessive mode
of inheritance as well [3],
We observed a diminished frequency of febrile attacks 
during pregnancy in the two patients with HIDS. This 
reminds us from similar findings in FMF where preg­
nancy and lactation have a beneficial influence on the 
symptoms [4]. These observations, made before the ad­
vent of colchicine, led to the employment of estrogens, 
progesterons or both for FMF with relative good thera­
peutic results. In HIDS, a hormonal influence cannot be 
discarded since statistical analysis revealed that 
menstruations often coincide or precede the febrile at­
tacks [2].
When our first patient presented with nausea, 
vomiting and abdominal pain, both an attack of HIDS 
and hyperemesis gravidarum were considered. While 
70% of pregnant women have a mild or moderate emesis 
gravidarum, which starts by 6 weeks of gestation and 
lasts until 16-20 weeks [5], only patients with
hyperemesis gravidarum (severe emesis) have dehydra­
tion, electrolyte disturbances and weight loss. An excess 
of human chorionic gonadotrophin (HCG) is often con­
sidered as an important factor in the pathogenesis since 
women with multiple pregnancies and hydatiform moles
have significantly higher HCG concentrations and a 
higher frequency of hyperemesis gravidarum. Although 
nausea and vomiting are symptoms of HIDS, an attack 
was ruled out because of the absence of fever.
The relation between the infection with S. 
Hemolyticus and HIDS in our second patient is most 
likely coincidental. An earlier analysis showed that these 
patients are not immunocompromised and do not carry
an increased risk for infections [1].
IgD constitutes only 0.2% of all serum im- 
munoglobulines and so far its function is not fully 
elucidated but it may be involved in the early antibody 
response. It has been suggested that IgD rises during 
pregnancy and in a group of 72 healthy females there 
was an exponential correlation between maternal IgD 
levels and gestational age at delivery [6]. In our two 
HIDS patients we were unable to find a significant rise 
of serum IgD during their pregnancies and even serum 
IgD of case 1 decreased to normal values. In healthy
pregnancies, the placenta is an effective barrier for IgD 
[7]. Our observation showed also that in a HIDS patient 
with very high IgD concentrations, IgD did not appear 
in cord blood.
This report is the first description of pregnancy in 
HIDS, but in FMF more data are available. Miscarriage 
is seen in 25-30% (in healthy individuals in 15%) in un­
treated patients, but also in patients on colchicine [4,8].
In animals colchicine has shown to be mutagenic. In 
1992 a report showed no unusual frequency of fetal ab­
normality among women with FMF taking colchicine 
before or during pregnancy [9]. Elaborate experience 
from Tel Hashomer, where more than 4000 FMF pa­
tients are presented, confirmed this. Although a signifi­
cant increase in the number of cells with abnormal
numbers of chromosomes was found in colchicine- 
exposed men, use of colchicine by the father does not 
present a significant risk. In FMF it is important to con­
tinue colchicine throughout the pregnancy not only be­
cause it is effectively suppressing the attacks, but it also 
prevents the development of amyloidosis.
In summary, our cases illustrate the following points: 
HIDS is not associated with complications in pregnancy
or disturbance in fetal outcome; the frequency of attacks 
diminishes during pregnancy; HIDS probably inherits 
via an autosomal recessive trait and is not transmitted 
to children of patients; lastly, IgD does not seem to cross 
the placenta even in a patient with very high IgD values.
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